LONDON (Reuters) - Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research centre, a decision critics said was bad for patients and research.


Source: http://uk.reuters.com/article/2012/02/02/uk-britain-jj-cancer-idUKTRE81100C20120202?feedType=RSS&feedName=domesticNews
technology pets food restaurants
No comments:
Post a Comment